Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1373 ARTÍCULOS , VIENDO DEL 826 AL 840

Intra-individual reaction time variability in mild cognitive impairment and Alzheimer's disease: gender, processing load and speed factors

Phillips M, Rogers P, Haworth J, Bayer A, Tales A.

PLoS One. 2013 Jun 10;8(6):e65712. doi: 10.1371/journal.pone.0065712. Print 2013.

Novel white matter tract integrity metrics sensitive to Alzheimer disease progression

Fieremans E, Benitez A, Jensen JH, Falangola MF, Tabesh A, Deardorff RL, Spampinato MV, Babb JS, Novikov DS, Ferris SH, Helpern JA.

AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2105-12. doi: 10.3174/ajnr.A3553. Epub 2013 Jun 13.

Evaluation of a computer-assisted errorless learning-based memory training program for patients with early Alzheimer's disease in Hong Kong: a pilot study

Lee GY, Yip CC, Yu EC, Man DW.

Clin Interv Aging. 2013;8:623-33. doi: 10.2147/CIA.S45726. Epub 2013 Jun 7.

Effectiveness of ramelteon for treatment of visual hallucinations in dementia with Lewy bodies: a report of 4 cases

Kasanuki K, Iseki E, Nishida Y, Fujishiro H, Chiba Y, Sato K, Arai H.

J Clin Psychopharmacol. 2013 Aug;33(4):581-3. doi: 10.1097/JCP.0b013e318295fdf4.

Melatonin for sundown syndrome and delirium in dementia: is it effective?

Lammers M, Ahmed AIA.

J Am Geriatr Soc. 2013 Jun;61(6):1045-1046. doi: 10.1111/jgs.12296.

Functional alteration patterns of default mode networks: comparisons of normal aging, amnestic mild cognitive impairment and Alzheimer's disease

Cha J, Jo HJ, Kim HJ, Seo SW, Kim HS, Yoon U, Park H, Na DL, Lee JM.

Eur J Neurosci. 2013 Jun;37(12):1916-24. doi: 10.1111/ejn.12177.

Medication adherence and tolerability of Alzheimer's disease medications: study protocol for a randomized controlled trial

Campbell NL, Dexter P, Perkins AJ, Gao S, Li L, Skaar TC, Frame A, Hendrie HC, Callahan CM, Boustani MA.

Trials. 2013 May 4;14:125. doi: 10.1186/1745-6215-14-125.

Perceptual and response interference in Alzheimer's disease and mild cognitive impairment

Wang P, Zhang X, Liu Y, Liu S, Zhou B, Zhang Z, Yao H, Zhang X, Jiang T.

Clin Neurophysiol. 2013 Dec;124(12):2389-96. doi: 10.1016/j.clinph.2013.05.014. Epub 2013 Jun 17.

[Relationship between memory disorders and self-consciousness in Alzheimer's disease]

Kalenzaga S, Clarys D.

Geriatr Psychol Neuropsychiatr Vieil. 2013 Jun;11(2):187-96. doi: 10.1684/pnv.2013.0403.

Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging

Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Hedrick S, Pappas V, Carrillo MC, Hartley DM; Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging.

Alzheimers Dement. 2013 Jul;9(4):e106-9. doi: 10.1016/j.jalz.2013.06.001.

Retrospective validation of WTAR and NART scores as estimators of prior cognitive ability using the Lothian Birth Cohort 1936

Dykiert D, Deary IJ.

Psychol Assess. 2013 Dec;25(4):1361-6. doi: 10.1037/a0033623. Epub 2013 Jul 1.

Socioeconomic status as a risk factor for dementia death: individual participant meta-analysis of 86 508 men and women from the UK

Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimäki M, Batty GD.

Br J Psychiatry. 2013 Jul;203(1):10-7. doi: 10.1192/bjp.bp.112.119479.

Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease

Daulatzai MA.

Neurotox Res. 2013 Oct;24(3):407-59. doi: 10.1007/s12640-013-9407-2. Epub 2013 Jul 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias